isospaglumic acid has been researched along with compstatin in 1 studies
| Studies (isospaglumic acid) | Trials (isospaglumic acid) | Recent Studies (post-2010) (isospaglumic acid) | Studies (compstatin) | Trials (compstatin) | Recent Studies (post-2010) (compstatin) |
|---|---|---|---|---|---|
| 469 | 31 | 116 | 100 | 1 | 57 |
| Protein | Taxonomy | isospaglumic acid (IC50) | compstatin (IC50) |
|---|---|---|---|
| Complement factor B | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradley, AJ; Devine, DV; Levin, E; Read, BL | 1 |
1 other study(ies) available for isospaglumic acid and compstatin
| Article | Year |
|---|---|
Small-molecule complement inhibitors cannot prevent the development of the platelet storage lesion.
Topics: Apoptosis; Blood Platelets; Blood Preservation; Caspase 3; Cell Survival; Dipeptides; Enzyme Activation; Humans; Peptides, Cyclic; Platelet Function Tests | 2008 |